Obesity Treatment
-
{
- All
- News
- Videos
-
Taking GLP-1 Weight-Loss Drugs? Here's How You Should Exercise To Preserve Muscle
- Wednesday November 4, 2026
- Health | Written by Sambhav Kumar
GLP-1 weight-loss medicines reduce appetite and aid fat loss but can also cause some muscle mass reduction.
-
www.ndtv.com/health
-
Will Weight-Loss Drugs Hurt Fast Food And Alcohol Companies? Harsh Goenka Flags Industry Shift
- Tuesday November 3, 2026
- Offbeat | Edited by Nikhil Pandey
Industrialist Harsh Goenka has highlighted the potential winners and losers, pointing to a major shift in consumer behaviour that businesses may need to prepare for.
-
www.ndtv.com
-
On GLP-1 Weight-Loss Drugs? How To Improve Your Body Shape
- Thursday October 29, 2026
- Health | Written by Sambhav Kumar
Improving body shape while taking GLP-1 weight-loss medications requires more than losing kilograms. Adequate protein, progressive resistance training, balanced nutrition, and cardiovascular activity.
-
www.ndtv.com/health
-
Ozempic-Maker Novo Nordisk Slims Down To 'Novo'
- Monday September 14, 2026
- Health | AFP
Danish pharmaceuticals giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced Monday a name change to just Novo, hoping it will be more...
-
www.ndtv.com/health
-
Beyond Appetite: New Study Reveals How GLP-1 Changes How Food Actually Tastes
- Wednesday August 5, 2026
- Health | Written by Debosmita Ghosh
The researchers reviewed evidence from different studies to understand how GLP-1 receptor agonists influence eating behaviour. Rather than focusing only on taste, they examined every stage of the eating experience, from sensing flavours to how the brain responds to food.
-
www.ndtv.com/health
-
NDTV Lifeline X Diabetes: Doctor Shares The Key Checks Before Prescribing Weight-Loss Injections
- Wednesday November 4, 2026
- Health | Written by Sambhav Kumar
Weight-loss injections like GLP-1 agonists aid diabetes and obesity but require thorough patient assessment before prescription.
-
www.ndtv.com/health
-
This Simple Blood Test Could Predict Which Weight-Loss Drug Will Work Best For You, Says Study
- Wednesday July 1, 2026
- Health | Written by Debosmita Ghosh
People with low GIP levels responded best to tirzepatide, regardless of their GLP-1 levels. On the other hand, those with low GLP-1 levels and medium to high GIP levels had the best response to semaglutide.
-
www.ndtv.com/health
-
Drugs Or Surgery For Obesity? Doctor Explains When That Becomes The Wrong Question
- Thursday June 18, 2026
- Health | Written by Dr Ashish Gautam
Bariatric surgery works by mechanisms that go far beyond reducing the volume of the stomach. These procedures, like sleeve gastrectomy and gastric bypass, change gut hormones, improve the body's sensitivity to insulin, alter appetite regulation and modify the body's metabolic response to food.
-
www.ndtv.com/health
-
Taking A Break? Study Finds Why Many GLP-1 Users Stop And Restart Their Medication
- Wednesday June 17, 2026
- Health | Written by Debosmita Ghosh
The findings provide insight into the challenges people face while using these medications and may help healthcare providers identify patients who need support to stay on treatment.
-
www.ndtv.com/health
-
AstraZeneca's Oral GLP-1 Drug Elecoglipron Drives Up To 11.8% Weight Loss In Trial
- Saturday June 13, 2026
- Health | Written by Debosmita Ghosh
The positive results come from the Phase 2 VISTA clinical trial, which evaluated elecoglipron in adults with obesity or overweight who also had at least one weight-related health condition.
-
www.ndtv.com/health
-
New Diabetes Drug Targets Metabolism, Avoids Ozempic Side Effects
- Thursday June 4, 2026
- Health | Written by Debosmita Ghosh
Early studies suggest that it can lower blood sugar levels and increase fat burning while preserving muscle mass and normal appetite. This makes it a good option for people who struggle with the nausea, appetite loss, and muscle reduction.
-
www.ndtv.com/health
-
Taking Ozempic? New Study Explains Why Pairing It With Exercise Is Important For Your Muscles
- Saturday May 30, 2026
- Health | Written by Debosmita Ghosh
Researchers found that combining semaglutide with regular exercise led to greater fat loss and better overall results than using the medication alone.
-
www.ndtv.com/health
-
Your Genes May Decide How Well Weight Loss Drugs Work: Study
- Monday May 18, 2026
- Health | Written by Sambhav Kumar
The research suggested that some of the same gene variants associated with better weight loss were also linked to stronger gastrointestinal side effects such as nausea or vomiting.
-
www.ndtv.com/health
-
Your Genes May Decide How Well Weight Loss Drugs Work: Study
- Monday May 18, 2026
- Health | Written by Sambhav Kumar
The research suggested that some of the same gene variants associated with better weight loss were also linked to stronger gastrointestinal side effects such as nausea or vomiting.
-
www.ndtv.com/health
-
FDA Approves New Weight-Loss Pill For Use At Any Time Of Day
- Thursday April 2, 2026
- Science | Edited by Nikhil Pandey
The US regulator has approved Eli Lilly's new oral weight-loss drug Foundayo through a fast-track process, offering a more convenient and potentially affordable alternative to injectable obesity treatments.
-
www.ndtv.com
-
Taking GLP-1 Weight-Loss Drugs? Here's How You Should Exercise To Preserve Muscle
- Wednesday November 4, 2026
- Health | Written by Sambhav Kumar
GLP-1 weight-loss medicines reduce appetite and aid fat loss but can also cause some muscle mass reduction.
-
www.ndtv.com/health
-
Will Weight-Loss Drugs Hurt Fast Food And Alcohol Companies? Harsh Goenka Flags Industry Shift
- Tuesday November 3, 2026
- Offbeat | Edited by Nikhil Pandey
Industrialist Harsh Goenka has highlighted the potential winners and losers, pointing to a major shift in consumer behaviour that businesses may need to prepare for.
-
www.ndtv.com
-
On GLP-1 Weight-Loss Drugs? How To Improve Your Body Shape
- Thursday October 29, 2026
- Health | Written by Sambhav Kumar
Improving body shape while taking GLP-1 weight-loss medications requires more than losing kilograms. Adequate protein, progressive resistance training, balanced nutrition, and cardiovascular activity.
-
www.ndtv.com/health
-
Ozempic-Maker Novo Nordisk Slims Down To 'Novo'
- Monday September 14, 2026
- Health | AFP
Danish pharmaceuticals giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced Monday a name change to just Novo, hoping it will be more...
-
www.ndtv.com/health
-
Beyond Appetite: New Study Reveals How GLP-1 Changes How Food Actually Tastes
- Wednesday August 5, 2026
- Health | Written by Debosmita Ghosh
The researchers reviewed evidence from different studies to understand how GLP-1 receptor agonists influence eating behaviour. Rather than focusing only on taste, they examined every stage of the eating experience, from sensing flavours to how the brain responds to food.
-
www.ndtv.com/health
-
NDTV Lifeline X Diabetes: Doctor Shares The Key Checks Before Prescribing Weight-Loss Injections
- Wednesday November 4, 2026
- Health | Written by Sambhav Kumar
Weight-loss injections like GLP-1 agonists aid diabetes and obesity but require thorough patient assessment before prescription.
-
www.ndtv.com/health
-
This Simple Blood Test Could Predict Which Weight-Loss Drug Will Work Best For You, Says Study
- Wednesday July 1, 2026
- Health | Written by Debosmita Ghosh
People with low GIP levels responded best to tirzepatide, regardless of their GLP-1 levels. On the other hand, those with low GLP-1 levels and medium to high GIP levels had the best response to semaglutide.
-
www.ndtv.com/health
-
Drugs Or Surgery For Obesity? Doctor Explains When That Becomes The Wrong Question
- Thursday June 18, 2026
- Health | Written by Dr Ashish Gautam
Bariatric surgery works by mechanisms that go far beyond reducing the volume of the stomach. These procedures, like sleeve gastrectomy and gastric bypass, change gut hormones, improve the body's sensitivity to insulin, alter appetite regulation and modify the body's metabolic response to food.
-
www.ndtv.com/health
-
Taking A Break? Study Finds Why Many GLP-1 Users Stop And Restart Their Medication
- Wednesday June 17, 2026
- Health | Written by Debosmita Ghosh
The findings provide insight into the challenges people face while using these medications and may help healthcare providers identify patients who need support to stay on treatment.
-
www.ndtv.com/health
-
AstraZeneca's Oral GLP-1 Drug Elecoglipron Drives Up To 11.8% Weight Loss In Trial
- Saturday June 13, 2026
- Health | Written by Debosmita Ghosh
The positive results come from the Phase 2 VISTA clinical trial, which evaluated elecoglipron in adults with obesity or overweight who also had at least one weight-related health condition.
-
www.ndtv.com/health
-
New Diabetes Drug Targets Metabolism, Avoids Ozempic Side Effects
- Thursday June 4, 2026
- Health | Written by Debosmita Ghosh
Early studies suggest that it can lower blood sugar levels and increase fat burning while preserving muscle mass and normal appetite. This makes it a good option for people who struggle with the nausea, appetite loss, and muscle reduction.
-
www.ndtv.com/health
-
Taking Ozempic? New Study Explains Why Pairing It With Exercise Is Important For Your Muscles
- Saturday May 30, 2026
- Health | Written by Debosmita Ghosh
Researchers found that combining semaglutide with regular exercise led to greater fat loss and better overall results than using the medication alone.
-
www.ndtv.com/health
-
Your Genes May Decide How Well Weight Loss Drugs Work: Study
- Monday May 18, 2026
- Health | Written by Sambhav Kumar
The research suggested that some of the same gene variants associated with better weight loss were also linked to stronger gastrointestinal side effects such as nausea or vomiting.
-
www.ndtv.com/health
-
Your Genes May Decide How Well Weight Loss Drugs Work: Study
- Monday May 18, 2026
- Health | Written by Sambhav Kumar
The research suggested that some of the same gene variants associated with better weight loss were also linked to stronger gastrointestinal side effects such as nausea or vomiting.
-
www.ndtv.com/health
-
FDA Approves New Weight-Loss Pill For Use At Any Time Of Day
- Thursday April 2, 2026
- Science | Edited by Nikhil Pandey
The US regulator has approved Eli Lilly's new oral weight-loss drug Foundayo through a fast-track process, offering a more convenient and potentially affordable alternative to injectable obesity treatments.
-
www.ndtv.com